David Steensma on Treatment Options for Myelodysplastic Syndromes
David Steensma, MD, Dana-Farber Cancer Institute, discusses treatment options for myelodysplastic syndromes.
David Steensma, MD, Dana-Farber Cancer Institute, discusses treatment options for myelodysplastic syndromes.
Steensma emphasizes that a one-size-fits-all approach does not work for treating these syndromes. Instead, patients, doctors, and nurses need to develop a plan based on factors such as risk associated with the disease and genetics.
Transplant holds the only possibility of cure, but patients who do not qualify and have certain genomic mutations can manage their condition with certain treatments or targeted therapies. For other patients, clinical trials are especially important as new drugs continue to be developed.
Oncology Nurses Provide Patients an Avenue to Supportive Care
November 12th 2019Palliative care is often associated with a patient entering end of life treatment and giving up on their treatment, but that isn't the reality of what id can do for patients. And oncology nurses can help guide patients to the right supportive care for them.
Hyman B. Muss Discusses the Importance of Nurses in Treating Pregnant Women With Breast Cancer
March 23rd 2016Hyman B. Muss, MD, professor of medicine at the University of North Carolina School of Medicine, discusses the vital roles that nurses play when it comes to treating pregnant women with breast cancer.
Kimberly J. Van Zee on Nomograms Helping in DCIS Treatment Decision-Making
March 18th 2016Kimberly J. Van Zee, MS, MD, FACS, attending surgeon at Memorial Sloan Kettering Cancer Center, discusses the institution's newly-developed nomogram that can help women make treatment decisions about ductal carcinoma in situ (DCIS).
